|
|
Publications in Math-Net.Ru |
Citations |
|
2022 |
1. |
Yu. A. Gaponov, V. I. Timofeev, Yu. K. Agapova, E. V. Bocharov, E. V. Shtykova, T. V. Rakitina, “Comparative structural analysis of a histone-like protein from <i>Spiroplasma melliferum</i> in the crystalline state and in solution”, Mendeleev Commun., 32:6 (2022), 742–744 |
4
|
|
2015 |
2. |
T. V. Rakitina, A. A. Zeifman, F. N. Novikov, O. V. Stroganov, V. S. Stroylov, I. Svitanko, A. Frank-Kamenetskii, G. G. Chilov, “Novel PARP1 inhibitors potentiate doxorubicin antitumor activity in vitro”, Mendeleev Commun., 25:5 (2015), 364–366 |
3
|
|
2012 |
3. |
T. V. Rakitina, A. A. Zeifman, I. Yu. Titov, I. Svitanko, A. V. Lipkin, V. S. Stroylov, O. V. Stroganov, F. N. Novikov, G. G. Chilov, “Efficacy of Novel Syk-Kinase Inhibitors MT-SYK-03 and MT-SYK-322 in Cellular Models of Autoimmunity and Cancer”, Mendeleev Commun., 22:6 (2012), 287–289 |
2
|
4. |
A. A. Zeifman, I. Yu. Titov, I. Svitanko, T. V. Rakitina, A. V. Lipkin, V. S. Stroylov, O. V. Stroganov, F. N. Novikov, G. G. Chilov, “Rational design and synthesis of novel Syk-kinase inhibitors”, Mendeleev Commun., 22:2 (2012), 73–74 |
10
|
|
2010 |
5. |
V. S. Stroylov, T. V. Rakitina, F. N. Novikov, O. V. Stroganov, G. G. Chilov, A. V. Lipkin, “Novel fragment-like inhibitors of EphA2 obtained by experimental screening and modelling”, Mendeleev Commun., 20:5 (2010), 263–265 |
10
|
|
Organisations |
|
|
|
|